|
US5710287A
(en)
|
1991-09-23 |
1998-01-20 |
Florida State University |
Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
|
|
US5998656A
(en)
|
1991-09-23 |
1999-12-07 |
Florida State University |
C10 tricyclic taxanes
|
|
US5990325A
(en)
|
1993-03-05 |
1999-11-23 |
Florida State University |
Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
|
|
US6495704B1
(en)
|
1991-09-23 |
2002-12-17 |
Florida State University |
9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
|
|
US6018073A
(en)
*
|
1991-09-23 |
2000-01-25 |
Florida State University |
Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
|
US6011056A
(en)
|
1991-09-23 |
2000-01-04 |
Florida State University |
C9 taxane derivatives and pharmaceutical compositions containing them
|
|
US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
|
US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
|
FR2696459B1
(fr)
*
|
1992-10-05 |
1994-11-25 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
|
US5973160A
(en)
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
|
US6339164B1
(en)
|
1993-01-29 |
2002-01-15 |
Florida State University |
C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6710191B2
(en)
|
1993-03-05 |
2004-03-23 |
Florida State University |
9β-hydroxytetracyclic taxanes
|
|
AU689770B2
(en)
*
|
1993-03-05 |
1998-04-09 |
Florida State University |
Process for the preparation of 9-desoxotaxanes
|
|
US5965566A
(en)
*
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
|
CA2178541C
(en)
|
1995-06-07 |
2009-11-24 |
Neal E. Fearnot |
Implantable medical device
|
|
US6262054B1
(en)
|
1996-02-01 |
2001-07-17 |
Sloan-Kettering Institute Of Cancer Research |
Combination therapy method for treating breast cancer using edatrexate
|
|
US5688977A
(en)
*
|
1996-02-29 |
1997-11-18 |
Napro Biotherapeutics, Inc. |
Method for docetaxel synthesis
|
|
US6545168B1
(en)
|
1996-05-06 |
2003-04-08 |
Florida State University |
1-deoxy baccatin III, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
|
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US7288665B1
(en)
|
1997-08-18 |
2007-10-30 |
Florida State University |
Process for selective derivatization of taxanes
|
|
CN1150149C
(zh)
|
1997-08-21 |
2004-05-19 |
佛罗里达州立大学 |
紫杉烷类化合物的合成方法
|
|
US20050192360A1
(en)
*
|
1999-04-14 |
2005-09-01 |
Li Chiang J. |
Method of treatment of pancreatic cancer
|
|
US20050222246A1
(en)
*
|
1999-04-14 |
2005-10-06 |
Li Chiang J |
Beta-lapachone is a broad spectrum anti-cancer agent
|
|
WO2001036007A2
(en)
*
|
1999-11-12 |
2001-05-25 |
Angiotech Pharmaceuticals, Inc. |
Compositions of a combination of radioactive therapy and cell-cycle inhibitors
|
|
AU2001288805A1
(en)
|
2000-09-22 |
2002-04-02 |
Bristol-Myers Squibb Company |
Method for reducing toxicity of combined chemotherapies
|
|
US7070797B2
(en)
*
|
2000-11-07 |
2006-07-04 |
Dana Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
|
US20050197405A1
(en)
*
|
2000-11-07 |
2005-09-08 |
Li Chiang J. |
Treatment of hematologic tumors and cancers with beta-lapachone, a broad spectrum anti-cancer agent
|
|
CA2440935A1
(en)
*
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
|
EP1800670A1
(en)
*
|
2001-04-20 |
2007-06-27 |
The University of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
|
EP1435965A4
(en)
*
|
2001-09-26 |
2005-09-21 |
Intermune Inc |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
|
|
US20030216758A1
(en)
*
|
2001-12-28 |
2003-11-20 |
Angiotech Pharmaceuticals, Inc. |
Coated surgical patches
|
|
US6816571B2
(en)
*
|
2002-02-06 |
2004-11-09 |
L-3 Communications Security And Detection Systems Corporation Delaware |
Method and apparatus for transmitting information about a target object between a prescanner and a CT scanner
|
|
CN1681495B
(zh)
|
2002-08-19 |
2010-05-12 |
辉瑞产品公司 |
用于治疗过度增生性疾病的组合物
|
|
AU2003273671A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Phytogen Life Sciences, Inc. |
Novel taxanes and methods related to use and preparation thereof
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
US7202370B2
(en)
*
|
2003-10-27 |
2007-04-10 |
Conor Medsystems, Inc. |
Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
|
|
ES2308451T3
(es)
|
2004-02-18 |
2008-12-01 |
Gpc Biotech Ag |
Satraplatino para el tratamiento de tumores resistentes o refractarios.
|
|
US20050187288A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Chiang Li |
Beta-lapachone and methods of treating cancer
|
|
US20050192247A1
(en)
*
|
2004-02-23 |
2005-09-01 |
Li Chiang J. |
Method of treating cancers
|
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
|
US7989490B2
(en)
*
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
|
CA2584493A1
(en)
|
2004-06-18 |
2006-01-05 |
Gpc Biotech, Inc. |
Kinase inhibitors for treating cancers
|
|
US20060135468A1
(en)
|
2004-09-02 |
2006-06-22 |
Bionaut Pharmaceuticals, Inc. |
Treatment of refractory cancers using NA+/K+ ATPase inhibitors
|
|
USH2260H1
(en)
|
2005-02-17 |
2011-07-05 |
Angiotech International Ag |
Stents combined with paclitaxel derivatives
|
|
US20070073385A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Cook Incorporated |
Eluting, implantable medical device
|
|
US7919108B2
(en)
*
|
2006-03-10 |
2011-04-05 |
Cook Incorporated |
Taxane coatings for implantable medical devices
|
|
US20080286325A1
(en)
*
|
2006-01-05 |
2008-11-20 |
Med Institute, Inc. |
Cyclodextrin elution media for medical device coatings comprising a taxane therapeutic agent
|
|
US7875284B2
(en)
*
|
2006-03-10 |
2011-01-25 |
Cook Incorporated |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
|
US7847111B2
(en)
*
|
2006-06-19 |
2010-12-07 |
Canada Inc. |
Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
|
|
EP2380606B1
(en)
|
2006-06-30 |
2018-03-21 |
Cook Medical Technologies LLC |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
|
US20080207743A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Rodger Lamb |
Biologically Active Taxane Analogs and Methods of Treatment
|
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
|
US8273404B2
(en)
*
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
|
US10517961B2
(en)
|
2015-09-25 |
2019-12-31 |
ZY Therapeutics, Inc. |
Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
ES2871499T3
(es)
|
2017-05-15 |
2021-10-29 |
Bard Inc C R |
Dispositivo médico con recubrimiento de elución de fármaco y capa intermedia
|
|
JP2021512110A
(ja)
|
2018-01-31 |
2021-05-13 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーGalera Labs, Llc |
ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
|
|
WO2019200181A1
(en)
|
2018-04-11 |
2019-10-17 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
|
EP3880266A1
(en)
|
2018-11-14 |
2021-09-22 |
Lutonix, Inc. |
Medical device with drug-eluting coating on modified device surface
|
|
WO2020209828A1
(en)
|
2019-04-08 |
2020-10-15 |
Bard Peripheral Vascular, Inc. |
Medical device with drug-eluting coating on modified device surface
|
|
AU2020348457A1
(en)
|
2019-09-19 |
2022-04-07 |
Leap Therapeutics, Inc. |
Use of DKK-1 inhibitors for treating cancer
|
|
BR112022009708A2
(pt)
|
2019-11-22 |
2022-08-09 |
Leap Therapeutics Inc |
Métodos de tratamento de câncer com uso de inibidores dkk-1
|